BA
LOXO

BlackRock Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

BlackRock Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$216K Sell
6,726
-277
-4% -$7.1K ﹤0.01% 2682
2016
Q3 		$183K Buy
7,003
+1,790
+34% +$46.8K ﹤0.01% 2734
2016
Q2 		$121K Buy
5,213
+1,061
+26% +$26.4K ﹤0.01% 2874
2016
Q1 		$114K Sell
4,152
-17,239
-81% -$361K ﹤0.01% 2858
2015
Q4 		$609K Sell
21,391
-14,647
-41% -$393K ﹤0.01% 1978
2015
Q3 		$630K Sell
36,038
-325
-0.9% -$6.36K ﹤0.01% 2020
2015
Q2 		$656K Buy
36,363
+11,694
+47% +$160K ﹤0.01% 1976
2015
Q1 		$307K Buy
24,669
+607
+3% +$7.56K ﹤0.01% 2427
2014
Q4 		$283K Buy
24,062
+22,848
+1,882% +$266K ﹤0.01% 2397
2014
Q3 		$16K Buy
+1,214
New +$15.8K ﹤0.01% 3539

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Advisors's LOXO Position: Q4 2016 in Review

BlackRock Advisors reduced its Loxo Oncology, Inc (LOXO) stake by 4% in Q4 2016, selling an estimated $7.1K and leaving 6,726 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #2682.

BlackRock Advisors first reported a position in LOXO in Q3 2014 and has held it in 10 quarters since. The position peaked at $656K in Q2 2015. 86 funds tracked by Wall St. Rank hold LOXO as of Q4 2016.

  • BlackRock Advisors held 6,726 shares of Loxo Oncology, Inc worth $216K as of Q4 2016.
  • BlackRock Advisors sold 277 Loxo Oncology, Inc shares in Q4 2016, an estimated $7.1K.
  • Loxo Oncology, Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2682 holding.
  • BlackRock Advisors first reported a position in Loxo Oncology, Inc in Q3 2014 and has held it in 10 quarters since.
  • BlackRock Advisors's Loxo Oncology, Inc position peaked at $656K in Q2 2015.
  • 86 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.